期刊文献+

Correlation of SFRP2 and TPX2 expression with cancer cell apoptosis and EMT process in cervical cancer

下载PDF
导出
摘要 Objective: To study the correlation of SFRP2 and TPX2 expression with cancer cell apoptosis and EMT process in cervical cancer. Methods: Patients with cervical cancer who received surgical resection in No.174 Hospital of PLA between June 2015 and December 2016 were selected as the research subjects, moderate amount of cervical cancer lesion and adjacent lesion were collected after surgical resection to extract RNA, and then fluorescent quantitative PCR kit was used to determine the expression of SFRP2, TPX2, apoptosis genes and EMT genes in lesion tissue. Results: SFRP2, SARI, AIF, FHIT, NDRG4, MCPH1 and E-cadherin mRNA expression in cervical cancer lesion were greatly lower than those in adjacent lesions whereas TPX2, SP2, CyclinD1, Piwil2, HERC4, EFEMP1, EZH2, TGF-β1, N-cadherin and Vimentin1 mRNA expression were greatly higher than those in adjacent lesions;SFRP2 mRNA expression in cervical cancer lesion was positively correlated with SARI, AIF, FHIT, NDRG4, MCPH1 and E-cadherin mRNA expression, and negatively correlated with SP2, CyclinD1, Piwil2, HERC4, EFEMP1, EZH2, TGF-β1, N-cadherin and Vimentin1 mRNA expression whereas TPX2 mRNA expression was negatively correlated with SARI, AIF, FHIT, NDRG4, MCPH1 and E-cadherin mRNA expression, and positively correlated with SP2, CyclinD1, Piwil2, HERC4, EFEMP1, EZH2, TGF-β1, N-cadherin and Vimentin1 mRNA expression. Conclusion: The lowly expressed SFRP2 and highly expressed TPX2 in cervical cancer lesions can inhibit the apoptosis of cancer cells and promote the EMT process of cancer cells.
出处 《Journal of Hainan Medical University》 2018年第1期109-112,共4页 海南医学院学报(英文版)
  • 相关文献

参考文献1

二级参考文献26

  • 1Su Z Z, Lee S G, Emdad L, et al. Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN) [J]. Proc Natl Acad Sci U S A, 2008, 105(52): 20906-20911.DOI:10.1073/pnas.0807975106.
  • 2Dorsey M J, Tae H J, Sollenberger K G, et al. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family[J]. Oncogene, 1995, 11(11): 2255-2265.
  • 3Dash R, Su Z Z, Lee S G, et al. Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1[J]. Oncogene, 2010, 29(31): 4412-4423. DOI:10.1038/onc.2010.194.
  • 4Ma H, Liang X, Chen Y, et al. Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma[J]. Int J Cancer, 2011, 128(4): 771-777. DOI:10.1002/ijc.25407.
  • 5Wang C, Su Y, Zhang L, et al. The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis[J]. PLoS One, 2012, 7(9): e38046. DOI:10.1371/journal.pone.0038046.
  • 6Wen H, Chen Y, Hu Z, et al. Decreased expression of BATF2 is significantly associated with poor prognosis in oral tongue squamous cell carcinoma[J]. Oncol Rep, 2014, 31(1): 169-174. DOI:10.3892/or.2013.2863.
  • 7Liu Z, Wei P, Yang Y, et al. BATF2 Deficiency Promotes Progression in Human Colorectal Cancer via Activation of HGF/MET Signaling: A Potential Rationale for Combining MET Inhibitors with IFNs[J]. Clin Cancer Res, 2015, 21(7): 1752-1763. DOI:10.1158/1078-0432.CCR-14-1564.
  • 8Meggiato T, Calabrese F, De-Cesare C M, et al. C-JUN and CPP32 (CASPASE 3) in human pancreatic cancer: relation to cell proliferation and death[J]. Pancreas, 2003, 26(1): 65-70.
  • 9Echlin D R, Tae H J, Mitin N, et al. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos[J]. Oncogene, 2000, 19(14): 1752-1763. DOI:10.1038/sj.onc.1203491.
  • 10Yen J H, Kocieda V P, Jing H, et al. Prostaglandin E2 induces matrix metalloproteinase 9 expression in dendritic cells through two independent signaling pathways leading to activator protein 1 (AP-1) activation[J]. J Biol Chem, 2011, 286(45): 38913-38923. DOI:10.1074/jbc.M111.252932.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部